ウェアラブル人工腎臓市場：病期、透析タイプ、エンドユーザー別-2025-2030年の世界予測

ウェアラブル人工腎臓市場は、2023年に1億8,019万米ドルと評価され、2024年には2億1,308万米ドルに達すると予測され、CAGR 18.74％で成長し、2030年には5億9,978万米ドルに達すると予測されています。

ウェアラブル人工腎臓（WAK）は、慢性腎臓病（CKD）患者に従来の臨床環境以外で腎代替療法を提供するために設計された革新的ヘルスケアです。この治療機器は、従来の透析方法と比較して、より高い移動性と柔軟性によって生活の質を向上させ、継続的な透析治療を提供することを目的としています。WAKの必要性は、高齢化、糖尿病、高血圧などの要因によってCKDの有病率が世界的に高まっていることに起因しています。WAKの用途は生命維持にとどまらず、感染リスクや心血管系の問題など、従来の透析に伴う合併症を軽減できる可能性があります。主なエンドユースシナリオには、在宅医療、外来診療所、遠隔地や十分なサービスを受けていない地域などがあり、大きな市場範囲を提供しています。公的・私的ヘルスケア支出の増加、小型化と生体適合性技術の進歩は重要な成長要因であり、市場の関心を後押ししています。新たなビジネスチャンスは、治療の個別化、遠隔医療サービスとの統合、WAKをより利用しやすくするための保険業者との提携にあります。しかし、研究開発コストの高さ、規制上の課題、安全性と有効性を確立するための大規模臨床試験の必要性などの制約があります。さらに、導入コストが高く、既存のヘルスケア・インフラとの統合が複雑であることも課題です。研究の革新は、電池寿命の延長、小型化、生体適合性の向上に焦点を当てるべきです。生体材料とろ過効率に関する研究は、技術的限界を押し広げる有望な分野です。さらに、個別化された患者ケアのための予測分析を提供するAI主導型モニタリングシステムの探求は、競争上の優位性をもたらす可能性があります。市場の性質はダイナミックで競争が激しく、臨床的、技術的、商業的なハードルに対処するためには学際的なアプローチが必要です。企業は、技術革新と規制遵守の両方に同時に取り組みながら、製品開発を最適化し、市場フットプリントを拡大するために、ハイテク企業や臨床団体との共同事業を重視すべきです。

市場力学：急速に進化するウェアラブル人工腎臓市場の主要市場インサイトを公開

ウェアラブル人工腎臓市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 糖尿病と高血圧の有病率の増加
  • ドナー不足による移植の制限
  • 様々な腎不全疾患、不健康なライフスタイルに対する意識の高まり
• 市場抑制要因
  • 透析製品に対する厳しい規制政策
• 市場機会
  • 人工腎臓の技術進歩
  • 外来透析を選択する患者の意識の高まり
• 市場の課題
  • 人工腎臓の使用による合併症のリスク

ポーターの5つの力：ウェアラブル人工腎臓市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ウェアラブル人工腎臓市場における外部からの影響の把握

外部マクロ環境要因は、ウェアラブル人工腎臓市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ウェアラブル人工腎臓市場における競合情勢の把握

ウェアラブル人工腎臓市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスウェアラブル人工腎臓市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ウェアラブル人工腎臓市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ウェアラブル人工腎臓市場における成功への道筋を描く

ウェアラブル人工腎臓市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 糖尿病と高血圧の増加
    • ドナーが少ないため、移植が制限される
    • さまざまな腎不全疾患、不健康なライフスタイルに関する意識の高まり
  • 抑制要因
    • 透析製品に対する厳格な規制政策
  • 機会
    • 人工腎臓の技術的進歩
    • 外来透析を選択する患者への意識を高める
  • 課題
    • 人工腎臓使用に伴う合併症のリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ウェアラブル人工腎臓市場病気のステージ別

• 急性腎疾患
• 末期腎疾患

第7章 ウェアラブル人工腎臓市場透析タイプ別

• 血液透析
• 腹膜透析

第8章 ウェアラブル人工腎臓市場：エンドユーザー別

• 外来手術センター
• 透析センター
• 病院

第9章 南北アメリカのウェアラブル人工腎臓市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のウェアラブル人工腎臓市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのウェアラブル人工腎臓市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• ANSELL LTD
• Asahi Kasei Medical Co., Ltd.
• AWAK Technologies
• B. Braun
• Baxter International Inc.
• Blood Purification Technologies Inc.
• Cardinal Health, Inc.
• Dynarex Corporation
• GE Healthcare
• Glove Corporation Bhd
• Hartalega Holdings
• Hitachi Medical Corporation
• KAWASUMI LABORATORIES, INC
• Koninklijke Philips N.V.
• Nanodialysis B.V.
• Semperit AG Holding
• Siemens AG
• Triomed AB

LIST OF FIGURES

• FIGURE 1. WEARABLE ARTIFICIAL KIDNEY MARKET RESEARCH PROCESS
• FIGURE 2. WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. WEARABLE ARTIFICIAL KIDNEY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. WEARABLE ARTIFICIAL KIDNEY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. WEARABLE ARTIFICIAL KIDNEY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. WEARABLE ARTIFICIAL KIDNEY MARKET DYNAMICS
• TABLE 7. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY ACUTE RENAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-STAGE RENAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. CHINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. INDIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. WEARABLE ARTIFICIAL KIDNEY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. WEARABLE ARTIFICIAL KIDNEY MARKET, FPNV POSITIONING MATRIX, 2023

The Wearable Artificial Kidney Market was valued at USD 180.19 million in 2023, expected to reach USD 213.08 million in 2024, and is projected to grow at a CAGR of 18.74%, to USD 599.78 million by 2030.

The Wearable Artificial Kidney (WAK) is a transformative healthcare innovation designed to provide renal replacement therapy for patients with chronic kidney disease (CKD) outside the traditional clinical settings. This device aims to offer continuous dialysis treatment, enhancing quality of life through greater mobility and flexibility compared to conventional dialysis methods. The necessity of WAKs stems from the growing prevalence of CKD globally, driven by factors such as aging populations, diabetes, and hypertension. Its applications extend beyond life support, potentially reducing complications associated with traditional dialysis, such as infection risks and cardiovascular issues. Key end-use scenarios include home care, outpatient clinics, and remote or underserved areas, providing a significant market scope. The rising public and private healthcare expenditures and advancements in miniaturization and biocompatibility technologies are critical growth factors, helping drive market interest. Emerging opportunities lie in the personalization of treatments, integration with telehealth services, and partnerships with insurance providers to make WAK more accessible. However, limitations include high R&D costs, regulatory challenges, and the need for substantial clinical trials to establish safety and efficacy. Moreover, the high costs of implementation and the complexity of integrating with existing healthcare infrastructure pose challenges. Research innovation should focus on enhancing battery life, reducing size, and improving biocompatibility. Studies on biomaterials and filtration efficiencies are promising areas for pushing technological boundaries. Additionally, exploring AI-driven monitoring systems to provide predictive analytics for personalized patient care could offer competitive advantages. The market nature is dynamic and highly competitive, with an interdisciplinary approach needed to address clinical, technological, and commercial hurdles. Companies should emphasize collaborative ventures with tech firms and clinical entities to optimize product development and expand their market footprint, addressing both technological innovations and regulatory compliance simultaneously.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Wearable Artificial Kidney Market

The Wearable Artificial Kidney Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of diabetes and hypertension
  • Low presence of donor, leading to limited transplantation
  • Rising awareness about various renal failure diseases, unhealthy lifestyles
• Market Restraints
  • Stringent regulatory policies for dialysis products
• Market Opportunities
  • Technological advancement in artificial kidney
  • Increase awareness among patients to opt for ambulatory dialysis
• Market Challenges
  • Risk of complications of using artificial kidney

Porter's Five Forces: A Strategic Tool for Navigating the Wearable Artificial Kidney Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Wearable Artificial Kidney Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Wearable Artificial Kidney Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Wearable Artificial Kidney Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Wearable Artificial Kidney Market

A detailed market share analysis in the Wearable Artificial Kidney Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Wearable Artificial Kidney Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Wearable Artificial Kidney Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Wearable Artificial Kidney Market

A strategic analysis of the Wearable Artificial Kidney Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Wearable Artificial Kidney Market, highlighting leading vendors and their innovative profiles. These include ANSELL LTD, Asahi Kasei Medical Co., Ltd., AWAK Technologies, B. Braun, Baxter International Inc., Blood Purification Technologies Inc., Cardinal Health, Inc., Dynarex Corporation, GE Healthcare, Glove Corporation Bhd, Hartalega Holdings, Hitachi Medical Corporation, KAWASUMI LABORATORIES, INC, Koninklijke Philips N.V., Nanodialysis B.V., Semperit AG Holding, Siemens AG, and Triomed AB.

Market Segmentation & Coverage

This research report categorizes the Wearable Artificial Kidney Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Disease Stage, market is studied across Acute Renal Disease and End-Stage Renal Disease.
• Based on Dialysis Type, market is studied across Hemodialysis and Peritoneal Dialysis.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Dialysis Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of diabetes and hypertension
    • 5.1.1.2. Low presence of donor, leading to limited transplantation
    • 5.1.1.3. Rising awareness about various renal failure diseases, unhealthy lifestyles
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulatory policies for dialysis products
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement in artificial kidney
    • 5.1.3.2. Increase awareness among patients to opt for ambulatory dialysis
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of complications of using artificial kidney
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Wearable Artificial Kidney Market, by Disease Stage

• 6.1. Introduction
• 6.2. Acute Renal Disease
• 6.3. End-Stage Renal Disease

7. Wearable Artificial Kidney Market, by Dialysis Type

• 7.1. Introduction
• 7.2. Hemodialysis
• 7.3. Peritoneal Dialysis

8. Wearable Artificial Kidney Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Dialysis Centers
• 8.4. Hospitals

9. Americas Wearable Artificial Kidney Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Wearable Artificial Kidney Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Wearable Artificial Kidney Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ANSELL LTD
• 2. Asahi Kasei Medical Co., Ltd.
• 3. AWAK Technologies
• 4. B. Braun
• 5. Baxter International Inc.
• 6. Blood Purification Technologies Inc.
• 7. Cardinal Health, Inc.
• 8. Dynarex Corporation
• 9. GE Healthcare
• 10. Glove Corporation Bhd
• 11. Hartalega Holdings
• 12. Hitachi Medical Corporation
• 13. KAWASUMI LABORATORIES, INC
• 14. Koninklijke Philips N.V.
• 15. Nanodialysis B.V.
• 16. Semperit AG Holding
• 17. Siemens AG
• 18. Triomed AB